A busy week of corporate earnings, a Fed meeting, a deluge of economic data and President Trump’s Aug. 1 tariff deadline are ...

On a Mission to Dominate British chip design titan Arm Holdings (NASDAQ:ARM) sent shockwaves through the tech industry ...

Elon Musk sees "rough quarters." A likely "robotaxi" launch in San Francisco comes with caveats. BYD is near a buy point.

Novo Nordisk (NYSE: NVO) and Regeneron Pharmaceuticals (NASDAQ: REGN), two leading drugmakers, have underperformed for most ...

And now analysts are stumbling over themselves to downgrade BYD's annual sales estimates. In fact, Deutsche Bank AG said it ...

At the risk of sounding like investing guru Cathie Wood, Tesla (NASDAQ:TSLA) has a clear path to be a $20 trillion stock. The pioneer in electric vehicles (EVs) and sustainable energy has transformed ...

Solesence shows strong growth and profitability with solid management alignment, but valuation reflects aggressive ...

Management is guiding for 2025 sales of $73.75 billion to $74.75 billion and free cash flow of $6.6 billion to $6.8 billion.

Harley-Davidson faces declining demand, high rates, and tariffs, eroding profits. See why analysts are issuing a 'sell' ...

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using ...

The disclosure sent UNH shares tumbling 4.7%, reflecting investor unease with the ongoing troubles with the healthcare stock.

CFOs looking to go public soon must nail forecasting, defend their most critical KPIs and incorporate pricing discipline in ...